SBRT2015

Starting your SABR program

• True improvements arising from local treatments are uncommon, and healthcare costs are important (cost- benefit ratio) • Avoid over-promising and under-delivering (e.g. proton therapy … )

• Developments in competing ablative therapies (RFA, Nanoknife® Irreversible Electroporation)